Earnings Scheduled For November 9, 2021
Companies Reporting Before The Bell
• Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter.
• KT (NYSE:KT) is projected to report earnings for its third quarter.
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Click here for accessing Benzinga's FDA Calendar
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 30)
Haemonetics’ Vascade Vascular Closure Device Includes Same-Day Discharge Label
Haemonetics Corp’s (NYSE:HAE) Vascade MVP Venous Vascular Closure System becomes the first vascular closure device to receive FDA indication for…
Haemonetics Announces VASCADE MVP Venous Vascular Closure System Gains The First And Only FDA Approval For Same-Day Discharge Following Atrial Fibrillation Ablation
Haemonetics Corporation (NYSE:HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced that the VASCADE MVP® Venous Vascular Closure
Looking into Haemonetics’s Return on Capital Employed
After pulling data from Benzinga Pro it seems like during Q1, Haemonetics (NYSE:HAE) posted sales of $228.53 million. Earnings were up 61.57%, but Haemonetics still reported an overall loss of $8.21 million.
The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 10)
Recap: Haemonetics Q1 Earnings
Shares of Haemonetics (NYSE:HAE) remained unaffected after the company reported Q1 results.
Quarterly Results
Earnings per share increased 8.70% year over year to $0.50, which beat the estimate of $0.46.
Haemonetics Q1 Adj. EPS $0.50 Beats $0.46 Estimate, Sales $229.00M Beat $219.35M Estimate; Raises FY22 Guidance For Vascular Closure Sales
Haemonetics (NYSE:HAE) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.46 by 8.7 percent. This is a 8.7 percent increase over earnings of $0.46 per share from the same
Earnings Scheduled For August 11, 2021
Companies Reporting Before The Bell
• Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.